Facet Wealth Inc’s AstraZeneca AZN Stock Holding History

Facet Wealth Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$309K	Buy	1,627 +211	+15%	+$39.7K	﹤0.01%	299
2026 Q1	$279K	Buy	1,416 +203	+17%	+$39.1K	﹤0.01%	272
2025 Q4	$226K	Buy	+1,213	New	+$213K	﹤0.01%	270

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Facet Wealth Inc's AZN Position: Q2 2026 in Review

Facet Wealth Inc increased its AstraZeneca (AZN) stake by 15% in Q2 2026, buying an estimated $39.7K and bringing the position to 1,627 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #299.

Facet Wealth Inc first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Facet Wealth Inc held 1,627 shares of AstraZeneca worth $309K as of Q2 2026.
Facet Wealth Inc bought 211 AstraZeneca shares in Q2 2026, an estimated $39.7K.
AstraZeneca made up ﹤0.01% of Facet Wealth Inc's portfolio in Q2 2026, its #299 holding.
Facet Wealth Inc first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Facet Wealth Inc's 13F filing for Q2 2026, filed 27 Jul 2026.